-+ 0.00%
-+ 0.00%
-+ 0.00%

Nasus Pharma Appoints Eyal Rubin As EVP And CFO

Benzinga·11/20/2025 13:16:37
Listen to the news

Nasus Pharma Ltd. (NYSE:NSRX) ("Nasus Pharma", "Nasus" or the "Company"), a clinical-stage pharmaceutical company focused on the development of innovative intranasal products to treat emergency medical conditions, today announced the appointment of Eyal Rubin as Executive Vice President and Chief Financial Officer. Mr. Rubin brings more than two decades of financial leadership experience in global biotechnology and pharmaceutical industries to Nasus Pharma's executive leadership team.

Mr. Rubin will lead and oversee Nasus Pharma's financial operations, including corporate finance, financial planning, capital strategy, and investor relations, as the Company advances its pipeline of intranasal therapeutics towards achieving key clinical and commercial milestones.